Oligomenorrhea
Infrequent menstrual periods occurring only a few times per year is called oligomenorrhea, which is clinically defined as menstrual cycle intervals persistently exceeding 45 days or cycles occurring between 36-90 days apart 1.
Clinical Definition and Terminology
Oligomenorrhea represents irregular, infrequent menstruation that falls between normal menstrual patterns and complete amenorrhea (absence of menses for ≥3 months). The Endocrine Society guidelines specifically identify oligomenorrhea as a key diagnostic criterion in multiple reproductive disorders 2, 1.
Key Distinguishing Features:
- Oligomenorrhea: Cycle length between 36-90 days (or persistently >45 days)
- Polymenorrhea: Cycle length <21 days (very rare, only 0.5% of women)
- Amenorrhea: Absence of menses for ≥3 months
- Normal variation: Cycles between 23-35 days in younger women, narrowing to 23-30 days in women aged 40-44 3
Clinical Context and Differential Diagnosis
When evaluating oligomenorrhea, the underlying etiology significantly impacts morbidity and requires systematic exclusion of organic pathology 1:
Common causes include:
- Polycystic Ovary Syndrome (PCOS): Oligomenorrhea combined with hyperandrogenism (clinical or biochemical) after excluding other pathologies 2
- Functional Hypothalamic Amenorrhea (FHA): Related to stress, energy imbalance, excessive exercise, or weight changes—requires evaluation when cycles persistently exceed 45 days 1
- Physiologic states: Normal in the first 1-2 years post-menarche and during perimenopause 2
Important Clinical Caveats
Adolescents: Oligomenorrhea should not be used alone to diagnose PCOS in adolescents, as anovulatory cycles comprise 85% of cycles in the first year after menarche, 59% in the third year, and normalize by the sixth year. Persistent oligomenorrhea beyond 2 years post-menarche warrants evaluation 2.
Diagnostic threshold: While individual cycle variation >14 days occurs in 29.3% of normal women, persistent patterns of cycles >45 days require investigation 3.
Overlap syndromes: Approximately half of patients with non-hyperandrogenic PCOS phenotype (oligomenorrhea plus polycystic ovarian morphology) may actually have FHA rather than PCOS 1.